ForDoz Pharma

Executive Summary

ForDoz Pharma is a US-based contract development and manufacturing organization (CDMO) specializing in sterile injectable drug products, including complex formulations such as liposomal, nanoparticle, microsphere, and long-acting injectables. Founded in 2018 and headquartered in San Diego, the company operates a state-of-the-art cGMP facility in East Windsor, New Jersey, offering end-to-end services from preclinical development to commercial-scale manufacturing. As a privately held, pre-clinical stage company, ForDoz Pharma is well-positioned to capitalize on the growing demand for sterile injectable manufacturing, particularly for complex generics and specialty pharmaceuticals. The CDMO market is experiencing robust growth driven by increasing outsourcing by pharmaceutical companies, and ForDoz's focus on advanced delivery technologies differentiates it from traditional injectable manufacturers.

Upcoming Catalysts (preview)

• Q3 2026Facility expansion or new capacity announcement70% success
• Q4 2026Strategic partnership with a major pharmaceutical company50% success
• Q1 2027Regulatory approval for a new manufacturing suite or technology platform60% success